We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents

Ben J. Marais, PhD1,2
[+] Author Affiliations
1The Children’s Hospital at Westmead, Sydney, Australia
2Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia
JAMA Pediatr. 2015;169(3):208-210. doi:10.1001/jamapediatrics.2014.3157.
Text Size: A A A
Published online


Tuberculosis is a major unrecognized cause of disease and death in young children living in tuberculosis-endemic settings.1 Recent estimates suggest that nearly a million children develop tuberculosis each year, although accurate quantification of the tuberculosis disease burden in children is hampered by difficulties in establishing an accurate diagnosis.2,3 Tuberculosis case loads are highly concentrated in areas affected by poverty and social disruption, but all countries are affected owing to increased international travel, population migration, and refugee resettlement.4 Awareness that children have a large tuberculosis burden that is preventable and treatable has increased following calls to action in 2010 and 2011.5,6 World Tuberculosis Day was dedicated to children in 2012, a new Roadmap for Childhood Tuberculosis launched in 2013,7 and a revised Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children published by the World Health Organization in 2014.8 Despite improved guidance and policies, implementation remains poor with major policy-practice gaps, especially regarding the provision of preventive therapy.9

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles